Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1970 1
1972 3
1973 2
1974 1
1976 3
1977 3
1978 3
1979 1
1980 3
1982 2
1984 2
1990 2
1991 1
1994 2
1998 2
2001 2
2002 2
2003 2
2004 4
2006 4
2007 4
2008 3
2009 1
2010 3
2012 1
2013 3
2014 3
2015 4
2016 2
2017 1
2018 2
2020 4
2021 3
2022 8
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
MRI contrasts in high rank rotating frames.
Liimatainen T, Hakkarainen H, Mangia S, Huttunen JM, Storino C, Idiyatullin D, Sorce D, Garwood M, Michaeli S. Liimatainen T, et al. Among authors: hakkarainen h. Magn Reson Med. 2015 Jan;73(1):254-62. doi: 10.1002/mrm.25129. Epub 2014 Feb 12. Magn Reson Med. 2015. PMID: 24523028 Free PMC article.
Black carbon toxicity dependence on particle coating: Measurements with a novel cell exposure method.
Hakkarainen H, Salo L, Mikkonen S, Saarikoski S, Aurela M, Teinilä K, Ihalainen M, Martikainen S, Marjanen P, Lepistö T, Kuittinen N, Saarnio K, Aakko-Saksa P, Pfeiffer TV, Timonen H, Rönkkö T, Jalava PI. Hakkarainen H, et al. Sci Total Environ. 2022 Sep 10;838(Pt 4):156543. doi: 10.1016/j.scitotenv.2022.156543. Epub 2022 Jun 6. Sci Total Environ. 2022. PMID: 35679919 Free article.
Towards zero pollution vehicles by advanced fuels and exhaust aftertreatment technologies.
Saarikoski S, Järvinen A, Markkula L, Aurela M, Kuittinen N, Hoivala J, Barreira LMF, Aakko-Saksa P, Lepistö T, Marjanen P, Timonen H, Hakkarainen H, Jalava P, Rönkkö T. Saarikoski S, et al. Among authors: hakkarainen h. Environ Pollut. 2024 Apr 15;347:123665. doi: 10.1016/j.envpol.2024.123665. Epub 2024 Mar 1. Environ Pollut. 2024. PMID: 38432344 Free article.
Toxicity of exhaust emissions from high aromatic and non-aromatic diesel fuels using in vitro ALI exposure system.
Hakkarainen H, Järvinen A, Lepistö T, Salo L, Kuittinen N, Laakkonen E, Yang M, Martikainen MV, Saarikoski S, Aurela M, Barreira L, Teinilä K, Ihalainen M, Aakko-Saksa P, Timonen H, Rönkkö T, Jalava P. Hakkarainen H, et al. Sci Total Environ. 2023 Sep 10;890:164215. doi: 10.1016/j.scitotenv.2023.164215. Epub 2023 May 23. Sci Total Environ. 2023. PMID: 37230343 Free article.
85 results